Abstract

New reconstruction algorithms based on deep learning have been developed to correct the image texture changes related to the use of iterative reconstruction algorithms. The purpose of this study was to evaluate the impact of a new deep learning image reconstruction [Advanced intelligent Clear-IQ Engine (AiCE)] algorithm on image-quality and dose reduction compared to a hybrid iterative reconstruction (AIDR 3D) algorithm and a model-based iterative reconstruction (FIRST) algorithm. Acquisitions were carried out using the ACR 464 phantom (and its body ring) at six dose levels (volume computed tomography dose index 15/10/7.5/5/2.5/1 mGy). Raw data were reconstructed using three levels (Mild/Standard/Strong) of AIDR 3D, of FIRST and AiCE. Noise-power-spectrum (NPS) and task-based transfer function (TTF) were computed. Detectability index was computed to model the detection of a small calcification (1.5-mm diameter and 500 HU) and a large mass in the liver (25-mm diameter and 120 HU). NPS peaks were lower with AiCE than with AIDR 3D (-41%±6% for all levels) or FIRST (-15%±6% for Strong level and -41%±11% for both other levels). The average NPS spatial frequency was lower with AICE than AIDR 3D (-9%±2% using Mild and -3%±2% using Strong) but higher than FIRST for Standard (6%±3%) and Strong (25%±3%) levels. For acrylic insert, values of TTF at 50 percent were higher with AICE than AIDR 3D and FIRST, except for Mild level (-6%±6% and -13%±3%, respectively). For bone insert, values of TTF at 50 percent were higher with AICE than AIDR 3D but lower than FIRST (-19%±14%). For both simulated lesions, detectability index values were higher with AICE than AIDR 3D and FIRST (except for Strong level and for the small feature; -21%±14%). Using the Standard level, dose could be reduced by -79% for the small calcification and -57% for the large mass using AICE compared to AIDR 3D. The new deep learning image reconstruction algorithm AiCE generates an image-quality with less noise and/or less smudged/smooth images and a higher detectability than the AIDR 3D or FIRST algorithms. The outcomes of our phantom study suggest a good potential of dose reduction using AiCE but it should be confirmed clinically in patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call